These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 19505204

  • 1. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L, Zhao Y, Foster TS, Fraser K, Bledsoe SL, Russell MW.
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [Abstract] [Full Text] [Related]

  • 2. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
    Wu N, Chen S, Boulanger L, Fraser K, Bledsoe SL, Zhao Y.
    J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The medical costs of migraine and comorbid anxiety and depression.
    Pesa J, Lage MJ.
    Headache; 2004 Jun; 44(6):562-70. PubMed ID: 15186300
    [Abstract] [Full Text] [Related]

  • 5. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients.
    Boulanger L, Zhao Y, Bao Y, Russell MW.
    BMC Health Serv Res; 2009 Jun 30; 9():111. PubMed ID: 19566952
    [Abstract] [Full Text] [Related]

  • 6. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
    Joyce AT, Smith P, Khandker R, Melin JM, Singh A.
    J Rheumatol; 2009 Apr 30; 36(4):743-52. PubMed ID: 19228658
    [Abstract] [Full Text] [Related]

  • 7. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan 30; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 8. Labor market, financial, insurance and disability outcomes among near elderly Americans with depression and pain.
    Tian H, Robinson RL, Sturm R.
    J Ment Health Policy Econ; 2005 Dec 30; 8(4):219-28. PubMed ID: 16385147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insomnia-related comorbidities and economic costs among a commercially insured population in the United States.
    Pollack M, Seal B, Joish VN, Cziraky MJ.
    Curr Med Res Opin; 2009 Aug 30; 25(8):1901-11. PubMed ID: 19530979
    [Abstract] [Full Text] [Related]

  • 12. The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.
    Zhu B, Zhao Z, Ye W, Marciniak MD, Swindle R.
    J Nerv Ment Dis; 2009 Feb 30; 197(2):136-9. PubMed ID: 19214050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review.
    Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS.
    Pain Med; 2007 Sep 30; 8 Suppl 2():S50-62. PubMed ID: 17714116
    [Abstract] [Full Text] [Related]

  • 15. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH, Bresnahan BW, Orsini LS, Kennedy S, Leonardi C.
    Curr Med Res Opin; 2004 Dec 30; 20(12):1929-36. PubMed ID: 15701211
    [Abstract] [Full Text] [Related]

  • 16. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
    Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R.
    Diabet Med; 2009 Jan 30; 26(1):61-9. PubMed ID: 19125762
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.
    Zhao Y, Ye W, Boye KS, Holcombe JH, Hall JA, Swindle R.
    J Diabetes Complications; 2010 Jan 30; 24(1):9-19. PubMed ID: 18930413
    [Abstract] [Full Text] [Related]

  • 18. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov 30; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 19. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.
    Ann Pharmacother; 2007 Nov 30; 41(11):1761-9. PubMed ID: 17895328
    [Abstract] [Full Text] [Related]

  • 20. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV, Joish VN, Camacho F, Drake CL.
    Curr Med Res Opin; 2010 Aug 30; 26(8):1843-53. PubMed ID: 20515321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.